FinTrust Capital Advisors’s CONMED CNMD Stock Holding History

FinTrust Capital Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25	Closed	-$2.52K	–	1273
2023 Q3	$2.52K	Buy	+25	New	+$2.87K	﹤0.01%	986
2022 Q4	–	Sell	-1,320	Closed	-$106K	–	1206
2022 Q3	$106K	Sell	1,320 -230	-15%	-$21.7K	0.03%	363
2022 Q2	$158K	Buy	1,550 +390	+34%	+$46.8K	0.04%	300
2022 Q1	$172K	Hold	1,160	–	–	0.04%	309
2021 Q4	$164K	Hold	1,160	–	–	0.04%	318
2021 Q3	$152K	Hold	1,160	–	–	0.04%	321
2021 Q2	$159K	Buy	1,160 +390	+51%	+$53.4K	0.04%	323
2021 Q1	$101K	Hold	770	–	–	0.03%	409
2020 Q4	$86K	Hold	770	–	–	0.03%	408
2020 Q3	$61K	Hold	770	–	–	0.01%	448
2020 Q2	$55K	Hold	770	–	–	0.02%	459
2020 Q1	$44K	Buy	+770	New	+$71K	0.02%	466

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

FinTrust Capital Advisors's CNMD Position: Q4 2023 in Review

FinTrust Capital Advisors sold out of CONMED (CNMD) in Q4 2023, closing a stake of 25 shares — an estimated $2.52K sold.

FinTrust Capital Advisors first reported a position in CNMD in Q1 2020 and held it in 12 quarters. The position peaked at $172K in Q1 2022. 306 funds tracked by Wall St. Rank hold CNMD as of Q4 2023.

FinTrust Capital Advisors reported no remaining CONMED position as of Q4 2023 after selling out during the quarter.
FinTrust Capital Advisors sold 25 CONMED shares in Q4 2023, an estimated $2.52K.
FinTrust Capital Advisors first reported a position in CONMED in Q1 2020 and held it in 12 quarters.
FinTrust Capital Advisors's CONMED position peaked at $172K in Q1 2022.
306 funds tracked by Wall St. Rank held CONMED as of Q4 2023.

Based on FinTrust Capital Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.